Drug Shortage Report for LOZIDE
Report ID | 130437 |
Drug Identification Number | 02179709 |
Brand name | LOZIDE |
Common or Proper name | LOZIDE |
Company Name | SERVIER CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | INDAPAMIDE |
Strength(s) | 1.25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | C03BA |
ATC description | LOW-CEILING DIURETICS, EXCL THIAZIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-12-18 |
Estimated end date | 2021-02-11 |
Actual end date | 2021-02-10 |
Shortage status | Resolved |
Updated date | 2021-02-10 |
Company comments | delays in shipment |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3224 AVENUE JEAN-BÉRAUD LAVAL, QUEBEC CANADA H7T 2S4 |
Company contact information | Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4 Phone : (450) 978-9700 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-02-10 | English | Compare |
v8 | 2021-02-05 | French | Compare |
v7 | 2021-02-05 | English | Compare |
v6 | 2021-02-05 | English | Compare |
v5 | 2021-01-25 | French | Compare |
v4 | 2021-01-25 | English | Compare |
v3 | 2020-12-19 | English | Compare |
v2 | 2020-12-18 | French | Compare |
v1 | 2020-12-18 | English | Compare |
Showing 1 to 9 of 9